<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Cardiovasc Disord</journal-id><journal-title-group><journal-title>BMC Cardiovascular Disorders</journal-title></journal-title-group><issn pub-type="epub">1471-2261</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21707993</article-id><article-id pub-id-type="pmc">3157429</article-id><article-id pub-id-type="publisher-id">1471-2261-11-36</article-id><article-id pub-id-type="doi">10.1186/1471-2261-11-36</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Erectile dysfunction, physical activity and metabolic syndrome: differences in markers of atherosclerosis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Pohjant&#x000e4;hti-Maaroos</surname><given-names>Hanna</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>hanna.pohjantahti-maaroos@kuh.fi</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Palom&#x000e4;ki</surname><given-names>Ari</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>ari.palomaki@khshp.fi</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Hartikainen</surname><given-names>Juha</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>juha.hartikainen@kuh.fi</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Emergency Medicine, Kanta-H&#x000e4;me Central Hospital, Ahvenistontie 20, FI-13530, H&#x000e4;meenlinna, Finland</aff><aff id="I2"><label>2</label>Department of Cardiometabolic Research, Linnan Klinikka, Raatihuoneenkatu 10, FI-13100, H&#x000e4;meenlinna, Finland</aff><aff id="I3"><label>3</label>Heart Center, Kuopio University Hospital, PL 1777, FI-70211 Kuopio, Finland</aff><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>27</day><month>6</month><year>2011</year></pub-date><volume>11</volume><fpage>36</fpage><lpage>36</lpage><history><date date-type="received"><day>14</day><month>3</month><year>2011</year></date><date date-type="accepted"><day>27</day><month>6</month><year>2011</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2011 Pohjant&#x000e4;hti-Maaroos et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2011</copyright-year><copyright-holder>Pohjant&#x000e4;hti-Maaroos et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-2261/11/36"/><abstract><sec><title>Background</title><p>Erectile dysfunction (ED), impaired arterial elasticity, elevated resting heart rate as well as increased levels of oxidized LDL and fibrinogen associate with future cardiovascular events. Physical activity is crucial in the prevention of cardiovascular diseases (CVD), while metabolic syndrome (MetS) comprises an increased risk for CVD events. The aim of this study was to assess whether markers of subclinical atherosclerosis are associated with the presence of ED and MetS, and whether physical activity is protective of ED.</p></sec><sec><title>Methods</title><p>57 MetS (51.3 &#x000b1; 8.0 years) and 48 physically active (PhA) (51.1 &#x000b1; 8.1 years) subjects participated in the study. ED was assessed by the International Index of Erectile Function (IIEF) questionnaire, arterial elasticity by a radial artery tonometer (HDI/PulseWave&#x02122; CR-2000) and circulating oxLDL by a capture ELISA immunoassay. Fibrinogen and lipids were assessed by validated methods. The calculation of mean daily energy expenditure of physical exercise was based on a structured questionnaire.</p></sec><sec><title>Results</title><p>ED was more often present among MetS compared to PhA subjects, 63.2% and 27.1%, respectively (p &#x0003c; 0.001). Regular physical exercise at the level of &#x0003e; 400 kcal/day was protective of ED (OR 0.12, 95% CI 0.017-0.778, p = 0.027), whereas increased fibrinogen (OR 4.67, 95% CI 1.171-18.627, p = 0.029) and elevated resting heart rate (OR 1.07, 95% CI 1.003-1.138, p = 0.04) were independently associated with the presence of ED. In addition, large arterial elasticity (ml/mmHgx10) was lower among MetS compared to PhA subjects (16.6 &#x000b1; 4.0 <italic>vs</italic>. 19.6 &#x000b1; 4.2, p &#x0003c; 0.001), as well as among ED compared to non-ED subjects (16.7 &#x000b1; 4.6 <italic>vs</italic>. 19.0 &#x000b1; 3.9, p = 0.008). Fibrinogen and resting heart rate were highest and large arterial elasticity lowest among subjects with both MetS and ED.</p></sec><sec><title>Conclusions</title><p>Markers of subclinical atherosclerosis associated with the presence of ED and were most evident among subjects with both MetS and ED. Thus, especially MetS patients presenting with ED should be considered at high risk for CVD events. Physical activity, on its part, seems to be protective of ED.</p></sec><sec><title>Trial registration</title><p>ClinicalTrials.gov <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov/ct2/show/NCT01119404">NCT01119404</ext-link></p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Atherosclerosis begins with oxidation of LDL particles in the arterial wall [<xref ref-type="bibr" rid="B1">1</xref>]. Oxidatively modified LDL (oxLDL) damages the endothelium of the artery - a pathophysiology similar to that of vascular erectile dysfunction (ED) [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. As a result, the elasticity of the arteries deteriorates. Impaired arterial elasticity and increased levels of circulating oxLDL as well as elevated fibrinogen and resting heart rate associate with subclinical atherosclerosis and increased risk of cardiovascular disease (CVD) events [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B8">8</xref>].</p><p>Besides similar pathophysiology, ED and CVD share same risk factors [<xref ref-type="bibr" rid="B9">9</xref>]. In addition, a high prevalence of both silent and clinical CVD has been reported among ED patients [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. ED has also been reported as an independent predictor of incident CVD [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. Since ED often precedes CVD symptoms from other vascular beds, it is thought to be an early clinical manifestation of systemic atherosclerosis [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B13">13</xref>].</p><p>Physical activity is known to be crucial in the prevention of CVD. Sedentary lifestyle, on its part, predisposes to metabolic syndrome (MetS), a clustering of metabolic disorders; visceral obesity, hypertension, dyslipidaemia and insulin resistance or diabetes [<xref ref-type="bibr" rid="B14">14</xref>]. MetS comprises a high risk for CVD events even in the absence of diabetes [<xref ref-type="bibr" rid="B15">15</xref>]. Mechanisms that link MetS to increased CVD risk are, however, incompletely understood.</p><p>In the present study we assessed arterial elasticity, circulating oxLDL levels, fibrinogen and resting heart rate among MetS and physically active (PhA) subjects. The aim was to study whether these markers of subclinical atherosclerosis associate with ED and MetS, and whether physical activity is protective of ED.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>120 men with MetS and 80 physically active (PhA) men participating in the H&#x000e4;meenlinna Metabolic Syndrome research program (HMS) were recruited in the study. MetS was diagnosed according to National Cholesterol Education Program (NCEP) criteria [<xref ref-type="bibr" rid="B16">16</xref>]. We interviewed the subjects on their medical history and lifestyle habits. Participation of a PhA subject was accepted if he exercised more than three times a week and 30 minutes per exercise on a regular basis without chest pain, dyspnea or fatigue, and did not fulfil the criteria of MetS. Exclusion criteria were non-specific beta-blocker medication and suspected non-vascular ED. Suspicion of non-vascular ED was based on patient records and patients' self-report during in the presence of possible psychogenic, urogenital, neurological or endocrinological cause for ED. Diagnoses of diabetes, hypertension and CVD were based on patients' report on previously diagnosed diseases, patient records and the use of antihyperglycemic, antihypertensive or antianginal medication. Positive family history of CVD was considered among subjects reporting previously diagnosed CVD in a first degree relative.</p><p>Subjects filled in a structured questionnaire on their average amount, type and intensity of leisure time physical exercise per week. The compendium of physical activities and subjects' self-rated intensity levels were used in estimating the metabolic equivalent (MET) values [<xref ref-type="bibr" rid="B17">17</xref>]. The energy expenditure of mean daily physical exercise was calculated in kilocalories by multiplying the MET value and exercise times per week and mean duration of exercise in hours and person's weight in kilograms and finally dividing it by seven. Physical activity level was considered low if mean daily energy expenditure of physical exercise was &#x0003c; 200 kcal/day, moderate if 200-400 kcal/day and high if &#x0003e; 400 kcal/day. In addition, waist circumference, height, weight and blood pressure were measured.</p><p>Each study subject signed an informed consent. The ethics committee of the Kanta-H&#x000e4;me Hospital District in Finland approved the study which was carried out in compliance with the Helsinki Declaration.</p></sec><sec><title>International Index of Erectile Dysfunction (IIEF) questionnaire</title><p>Subjects filled in the IIEF questionnaire [<xref ref-type="bibr" rid="B18">18</xref>]. The sum of the questions 1-5 and 15 was calculated to assess the presence of ED. Subjects with maximal score of 30 were considered to have normal erectile function and subjects with score of &#x02264;25, were considered to have ED. To ensure that the study subjects truly had either completely normal or impaired erectile function, subjects with IIEF score 26 to 29 were excluded. The question number 15 (how do you rate your confidence that you can get and keep your erection?) was used to assess the presence of erectile function in men reporting lack of sexual activity in questions 1-5. A subject reporting very high confidence in the question number 15, was considered to have normal erectile function. Those reporting very low to medium confidence were considered to have ED, and those reporting high confidence were excluded.</p></sec><sec><title>Arterial elasticity and laboratory procedures</title><p>Arterial elasticity was assessed by a non-invasive radial artery tonometer (HDI/PulseWave&#x02122;CR-2000) in a semi-sitting position. Arterial tonometer uses a modified Windkessel method to estimate systemic large (C1) and small (C2) arterial elasticity [<xref ref-type="bibr" rid="B3">3</xref>]. C1 identifies the elasticity of the aorta and other large arteries, C2 the elasticity and endothelial function of the microvascular circulation. Indices determined by this validated method correlate tightly with those determined invasively [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. In addition, C1 seems to correlate significantly with MRI-determined aortic distensibility, whereas C2 correlate with endothelial function assessed by flow-mediated dilation [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>]. In addition, elasticity indices assessed by the HDI/Pulsewave&#x02122;CR-2000 have been reported reliable and repeatable over a short and long period of observation [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. The reference values depend on age and gender. Among men aged 50-59 years, C1 above 11 ml/mmHgx10 and C2 above 7 ml/mmHgx100 are considered normal.</p><p>Arterial elasticity indices were assessed automatically by the tonometer as a mean of five most similar pulse waves appearing during 30 seconds of measurement. Mean of four consecutive measurements was assessed. Blood pressure and resting heart rate were automatically measured by the CR-2000 during the elasticity measurement. Intraindividual CV% was 9.0% for C1 and 8.8% for C2. Same experienced nurse performed all measurements.</p><p>Plasma levels of oxLDL were determined as duplicates by a capture ELISA immunoassay (Mercodia AB, Uppsala, Sweden). It uses the same monoclonal antibody as in the assays by Holvoet et al [<xref ref-type="bibr" rid="B6">6</xref>]. CV% of oxLDL measurement was 7.7%. Fibrinogen and lipids were assessed by validated methods.</p></sec><sec><title>Statistical methods</title><p>Statistics were analyzed with SPSS for Windows 17.0. Data are presented as mean &#x000b1; SD if not mentioned otherwise. A probability value &#x0003c; 0.05 was considered statistically significant.</p><p>Student's T-test was used in assessing the differences between subjects with ED and normal erectile function as well as between MetS and PhA subjects in case of normality. Mann Whitney U-test was used in case of non-normality. ANOVA was used to analyze the adjusted p values for differences in two-dimensional variables as well as in four-dimensional variables in case of normality. Bonferroni post hoc analysis was used for multiple comparisons regarding fibrinogen, resting heart rate and arterial elasticity. The differences were adjusted for age, smoking, blood pressure, diabetes, CVD, and LDL cholesterol. Kruskall-Wallis test was used in case of non-normality. Differences in categorical values were calculated by &#x003c7;<sup>2 </sup>test. Univariate and multivariate analyses of the associations between risk factors and markers of CVD and the presence of ED were conducted with binary logistic regression model. Traditional CVD risk factors and assessed markers of subclinical atherosclerosis without strong correlation with each other were included as covariates in the multivariate analysis. Multivariate analysis was conducted with the enter method by removing covariates without association to ED one by one. The result was verified with the forward conditional method and adjusted for the use of medications. OR, 95% CI and p values for covariates in the univariate analyses and for significant covariates in the adjusted multivariate analysis, as well as Nagelkerke R<sup>2 </sup>of the final model are presented.</p></sec></sec><sec><title>Results</title><p>Fifty-seven MetS and 48 PhA subjects without exclusion criteria completed the IIEF questionnaire. Ten men with MetS and four PhA men reported lack of sexual activity. All except one of these 14 men were diagnosed with ED according to the question number 15. Altogether ten men with MetS had previously diagnosed CVD. There were four patients with coronary artery disease, three with cerebrovascular disease, two with coronary artery and cerebrovascular disease and one with coronary artery and peripheral artery disease. ED was more often present among MetS compared to PhA subjects, 36 (63.2%) and 13 (27.1%), respectively (p &#x0003c; 0.001) (Figure <xref ref-type="fig" rid="F1">1</xref>). Clinical characteristics and medications of the study groups are presented in Table <xref ref-type="table" rid="T1">1</xref> and clinical chemistry in Table <xref ref-type="table" rid="T2">2</xref>. None of the study subjects used PDE5-inhibitors.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Prevalence of erectile dysfunction (ED) among metabolic syndrome (MetS) and physically active (PhA) subjects</bold>.</p></caption><graphic xlink:href="1471-2261-11-36-1"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Clinical characteristics of study subjects.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="6"><hr/></td></tr><tr><td/><td align="center">&#x02003;&#x02003;<bold>PhA</bold></td><td/><td align="center">&#x02003;&#x02003;<bold>MetS</bold></td><td/><td/></tr><tr><td/><td align="left"><bold>no ED</bold></td><td align="left"><bold>ED</bold></td><td align="left"><bold>no ED</bold></td><td align="left"><bold>ED</bold></td><td align="center"><bold>p</bold></td></tr><tr><td/><td align="left"><bold>(n = 35)</bold></td><td align="left"><bold>(n = 13)</bold></td><td align="left"><bold>(n = 21)</bold></td><td align="left"><bold>(n = 36)</bold></td><td/></tr><tr><td colspan="6"><hr/></td></tr><tr><td align="left">Age<sup>1</sup>, years</td><td align="left">49.4 &#x000b1; 7.5</td><td align="left">56.9 &#x000b1; 6.7</td><td align="left">45.9 &#x000b1; 4.6</td><td align="left">54.1 &#x000b1; 8.2</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left">CVD in family, n (%)</td><td align="left">18 (51.4%)</td><td align="left">9 (69.0%)</td><td align="left">1 (52.3%)</td><td align="left">18 (50.0%)</td><td align="center">NS</td></tr><tr><td align="left">Diagnosed CVD<sup>b</sup>, n (%)</td><td align="left">0 (0%)</td><td align="left">0 (0%)</td><td align="left">3 (14.3%)</td><td align="left">7 (19.4%)</td><td align="center">&#x0003c; 0.05</td></tr><tr><td align="left">Diabetics<sup>2,a</sup>, n (%)</td><td align="left">0 (0%)</td><td align="left">0 (0%)</td><td align="left">7 (33.3%)</td><td align="left">19 (52.8%)</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left">Hypertension<sup>2,a</sup>, n (%)</td><td align="left">1 (2.9%)</td><td align="left">3 (23.1%)</td><td align="left">11 (52.4%)</td><td align="left">20 (55.6%)</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left">ASA<sup>c</sup>, n (%)</td><td align="left">4 (11.4%)</td><td align="left">0 (0%)</td><td align="left">5 (23.8%)</td><td align="left">10 (27.8%)</td><td align="center">NS</td></tr><tr><td align="left">&#x003b2;<sub>1</sub>-blocker<sup>2,a</sup>, n (%)</td><td align="left">0 (0%)</td><td align="left">1 (7.7%)</td><td align="left">4 (19.0%)</td><td align="left">15 (41.7%)</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left">ACE-inhibitor, n (%)</td><td align="left">1 (2.9%)</td><td align="left">2 (15.4%)</td><td align="left">2 (9.5%)</td><td align="left">4 (11.1%)</td><td align="center">NS</td></tr><tr><td align="left">ATR-blocker<sup>a</sup>, n (%)</td><td align="left">0 (0%)</td><td align="left">0 (0%)</td><td align="left">5 (23.8%)</td><td align="left">11 (30.6%)</td><td align="center">&#x0003c; 0.01</td></tr><tr><td align="left">Ca-blocker, n (%)</td><td align="left">0 (0%)</td><td align="left">1 (7.7%)</td><td align="left">1 (4.8%)</td><td align="left">3 (8.3%)</td><td align="center">NS</td></tr><tr><td align="left">Diuretic<sup>b</sup>, n (%)</td><td align="left">0 (0%)</td><td align="left">1 (7.7%)</td><td align="left">4 (19.0%)</td><td align="left">8 (22.2%)</td><td align="center">&#x0003c; 0.05</td></tr><tr><td align="left">Statin<sup>b</sup>, n (%)</td><td align="left">4 (11.4%)</td><td align="left">2 (15.4%)</td><td align="left">7 (33.3%)</td><td align="left">14 (38.9%)</td><td align="center">&#x0003c; 0.05</td></tr><tr><td align="left">Smoking<sup>b</sup></td><td/><td/><td/><td/><td align="center">&#x0003c; 0.01</td></tr><tr><td align="left">-current, n (%)</td><td align="left">1 (2.9%)</td><td align="left">0 (0%)</td><td align="left">5 (23.8%)</td><td align="left">6 (16.7%)</td><td/></tr><tr><td align="left">-former, n (%)</td><td align="left">11 (31.4%)</td><td align="left">6 (46.2%)</td><td align="left">10 (47.6%)</td><td align="left">18 (50.0%)</td><td/></tr><tr><td align="left">-never, n (%)</td><td align="left">23 (65.7%)</td><td align="left">7 (53.8%)</td><td align="left">6 (28.6%)</td><td align="left">12 (33.3%)</td><td/></tr><tr><td align="left">Physical activity<sup>2,a</sup>, kcal/day</td><td align="left">506.9 &#x000b1; 300</td><td align="left">467.1 &#x000b1; 256</td><td align="left">209.4 &#x000b1; 265</td><td align="left">156.4 &#x000b1; 172</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left">Alcohol intake<sup>b</sup>, g/day</td><td align="left">7.8 &#x000b1; 6.0</td><td align="left">6.0 &#x000b1; 4.3</td><td align="left">15.0 &#x000b1; 13.5</td><td align="left">20.1 &#x000b1; 22.8</td><td align="center">&#x0003c; 0.01</td></tr><tr><td align="left">BMI<sup>2,a</sup>, kg/m<sup>2</sup></td><td align="left">23.8 &#x000b1; 2.0</td><td align="left">24.6 &#x000b1; 3.0</td><td align="left">32.7 &#x000b1; 4.5</td><td align="left">32.0 &#x000b1; 4.8</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left">Waist circumf.<sup>2,a</sup>, cm</td><td align="left">88.6 &#x000b1; 7.1</td><td align="left">90.8 &#x000b1; 8.9</td><td align="left">113.5 &#x000b1; 10.5</td><td align="left">114.8 &#x000b1; 13.3</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left">SBP<sup>3,a</sup>, mmHg</td><td align="left">127.2 &#x000b1; 9.2</td><td align="left">126.9 &#x000b1; 11.2</td><td align="left">136.5 &#x000b1; 12.2</td><td align="left">139.8 &#x000b1; 16.5</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left">DBP<sup>a</sup>, mmHg</td><td align="left">73.9 &#x000b1; 6.7</td><td align="left">74.5 &#x000b1; 5.6</td><td align="left">82.1 &#x000b1; 7.4</td><td align="left">81.7 &#x000b1; 8.8</td><td align="center">&#x0003c; 0.001</td></tr></tbody></table><table-wrap-foot><p><sup>1-3 </sup>p value for the difference between men with and without ED: <sup>1 </sup>p &#x0003c; 0.001, <sup>2 </sup>p &#x0003c; 0.01, <sup>3 </sup>p &#x0003c; 0.05. NS if not mentioned.</p><p><sup>a-c </sup>p value for the difference between PhA and MetS subjects: <sup>a </sup>p &#x0003c; 0.001, <sup>b </sup>p &#x0003c; 0.01, <sup>c </sup>p &#x0003c; 0.05. NS if not mentioned.</p><p>ASA - acetylsalicylic acid; ATR - angiotensin receptor; BMI - body mass index; CVD - cardiovascular disease; DBP - diastolic blood pressure; ED - erectile dysfunction; MetS - metabolic syndrome; PhA - physically active; SBP - systolic blood pressure</p></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Clinical chemistry of study subjects.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th align="center" colspan="2">PhA</th><th align="center" colspan="2">MetS</th><th/></tr><tr><th/><th align="center">no ED</th><th align="center">ED</th><th align="center">no ED</th><th align="center">ED</th><th align="center">p</th></tr><tr><th/><th align="center">(n = 35)</th><th align="center">(n = 13)</th><th align="center">(n = 21)</th><th align="center">(n = 36)</th><th/></tr></thead><tbody><tr><td align="left">Cholesterol, mmol/L</td><td align="center">5.27 &#x000b1; 0.7</td><td align="center">5.33 &#x000b1; 0.8</td><td align="center">5.26 &#x000b1; 1.1</td><td align="center">5.30 &#x000b1; 1.6</td><td align="center">NS</td></tr><tr><td align="left">LDL-C, mmol/L</td><td align="center">3.47 &#x000b1; 0.7</td><td align="center">3.32 &#x000b1; 0.9</td><td align="center">3.24 &#x000b1; 0.9</td><td align="center">3.21 &#x000b1; 1.0</td><td align="center">NS</td></tr><tr><td align="left">HDL-C<sup>3,a</sup>, mmol/L</td><td align="center">1.61 &#x000b1; 0.3</td><td align="center">1.81 &#x000b1; 0.4</td><td align="center">1.20 &#x000b1; 0.2</td><td align="center">1.16 &#x000b1; 0.3</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left">Triglycerides<sup>3,a</sup>, mmol/L</td><td align="center">0.94 &#x000b1; 0.5</td><td align="center">0.86 &#x000b1; 0.4</td><td align="center">2.49 &#x000b1; 1.4</td><td align="center">3.19 &#x000b1; 5.1</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left">OxLDL, U/L</td><td align="center">71.8 &#x000b1; 21.4</td><td align="center">75.5 &#x000b1; 35.5</td><td align="center">78.5 &#x000b1; 40.1</td><td align="center">80.8 &#x000b1; 33.5</td><td align="center">NS</td></tr><tr><td align="left">Glucose<sup>2,a</sup>, mmol/L</td><td align="center">5.49 &#x000b1; 0.4</td><td align="center">5.59 &#x000b1; 0.6</td><td align="center">6.54 &#x000b1; 1.0</td><td align="center">6.99 &#x000b1; 2.2</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left">HbA1C<sup>2,a</sup>,%</td><td align="center">5.61 &#x000b1; 0.2</td><td align="center">5.60 &#x000b1; 0.2</td><td align="center">6.03 &#x000b1; 0.6</td><td align="center">6.47 &#x000b1; 1.2</td><td align="center">&#x0003c; 0.001</td></tr></tbody></table><table-wrap-foot><p>ED - erectile dysfunction; HbA1C - glycosylated haemoglobin; HDL-C - high density lipoprotein cholesterol; LDL-C - low density lipoprotein cholesterol; MetS - metabolic syndrome; OxLDL - oxidized LDL; PhA - physically active. Upper indices for p values as in Table 1.</p></table-wrap-foot></table-wrap><p>There was an evident difference in the amount of daily physical exercise between PhA and MetS subjects, 496.7 &#x000b1; 286.9 kcal/day <italic>vs</italic>. 176.3 &#x000b1; 210.8 kcal/day, respectively (p &#x0003c; 0.001). In addition, subjects with normal erectile function were physically more active compared to subjects with ED, 395.3 &#x000b1; 319.5 kcal/day <italic>vs</italic>. 235.7 &#x000b1; 237.3 kcal/day, respectively (p = 0.005). Physical activity of the study groups is presented in Table <xref ref-type="table" rid="T1">1</xref>.</p><p>Fibrinogen was lower among PhA compared to MetS subjects, 2.90 &#x000b1; 0.47 g/L <italic>vs</italic>. 3.53 &#x000b1; 0.82 g/L, respectively (p &#x0003c; 0.001). Furthermore, fibrinogen levels were lower among subjects with normal erectile function compared to those with ED, 3.00 &#x000b1; 0.50 g/L <italic>vs</italic>. 3.51 &#x000b1; 0.89 g/L, respectively (p = 0.001). Fibrinogen levels were 2.91 &#x000b1; 0.4 g/L among PhA subjects without ED, 2.87 &#x000b1; 0.6 g/L among PhA subjects with ED, 3.16 &#x000b1; 0.6 g/L among MetS subjects without ED, and 3.74 &#x000b1; 0.9 g/L among MetS subjects with ED (Figure <xref ref-type="fig" rid="F2">2</xref>). There were no significant differences in oxLDL levels between any of the groups (Table <xref ref-type="table" rid="T2">2</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Fibrinogen levels (g/L) between the study groups (n = 105)</bold>. Mean &#x000b1; SEM is presented. P values after adjustment for age, smoking, blood pressure, established CVD, diabetes and LDL cholesterol, <sup>a </sup>p &#x0003c; 0.001, <sup>b </sup>p &#x0003c; 0.01, <sup>c </sup>p &#x0003c; 0.05.</p></caption><graphic xlink:href="1471-2261-11-36-2"/></fig><p>Resting heart rate was lower among PhA compared to MetS subjects, 52.5 &#x000b1; 9.6 beats/min <italic>vs</italic>. 65.1 &#x000b1; 10.0 beats/min (p &#x0003c; 0.001). The difference remained significant after adjustment for age and selective &#x003b2;-blocker medication (p &#x0003c; 0.001). Resting heart rate was also lower among subjects with normal erectile function, compared to those with ED, 55.6 &#x000b1; 9.8 beats/min <italic>vs</italic>. 63.5 &#x000b1; 12.3 beats/min (p = 0.001). After adjustment for age and selective &#x003b2;-blocker medication, the difference remained significant (p = 0.001). Resting heart rate was 51.9 &#x000b1; 9.0 beats/min among PhA subjects without ED, 54.3 &#x000b1; 11.4 beats/min among PhA subjects with ED, 62.3 &#x000b1; 7.6 beats/min among MetS subjects without ED, and 66.8 &#x000b1; 11.0 beats/min among MetS subjects with ED (Figure <xref ref-type="fig" rid="F3">3</xref>).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Resting heart rate (beats/min) between the study groups (n = 105)</bold>. Mean &#x000b1; SEM is presented. P values after adjustment for age, smoking, blood pressure, established CVD, diabetes and LDL cholesterol, <sup>b </sup>p &#x0003c; 0.01, <sup>c </sup>p &#x0003c; 0.05.</p></caption><graphic xlink:href="1471-2261-11-36-3"/></fig><p>PhA subjects had better large arterial elasticity (C1) compared to MetS subjects, 19.6 &#x000b1; 4.2 ml/mmHgx10 and 16.6 &#x000b1; 4.0 ml/mmHgx10, respectively (p &#x0003c; 0.001). There was no difference between the groups in small arterial elasticity (C2). Subjects with normal erectile function had better C1 compared to those with ED, 19.0 &#x000b1; 3.9 ml/mmHgx10 and 16.7 &#x000b1; 4.6 ml/mmHgx10, respectively (p = 0.008). Also C2 was better among those with normal erectile function compared to those with ED, 7.5 &#x000b1; 3.2 ml/mmHgx100 and 6.2 &#x000b1; 3.0 ml/mmHgx100, respectively (p = 0.035). The difference in C1 remained significant even after adjustment for age (p = 0.035) and the use of selective &#x003b2;-blockers (p = 0.026). After the same adjustment the difference in C2 did not remain significant. C1 was 19.7 &#x000b1; 4.1 ml/mmHgx10 among PhA subjects without ED, 19.0 &#x000b1; 4.7 ml/mmHgx10 among PhA subjects with ED, 17.8 &#x000b1; 3.1 ml/mmHgx10 among MetS subjects without ED and 15.9 &#x000b1; 4.4 ml/mmHgx10 among MetS subjects with ED (Figure <xref ref-type="fig" rid="F4">4</xref>). C2 was 7.2 &#x000b1; 2.7 ml/mmHgx100, 6.7 &#x000b1; 3.3 ml/mmHgx100, 8.1 &#x000b1; 3.9 ml/mmHgx100, and 6.0 &#x000b1; 2.9 ml/mmHgx100, respectively (NS).</p><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Large arterial elasticity (C1, ml/mmHgx10) between the study groups (n = 105)</bold>. Mean &#x000b1; SEM is presented. After adjustment for age, smoking, blood pressure, established CVD, diabetes and LDL cholesterol, the differences were not significant.</p></caption><graphic xlink:href="1471-2261-11-36-4"/></fig><p>Results of the univariate analyses are presented in Table <xref ref-type="table" rid="T3">3</xref>. MetS associated with the presence of ED even after adjustment for age, physical activity, smoking and total cholesterol (OR = 5.83, 95% CI 1.730-19.618, p = 0.004). The association of MetS and ED did not remain significant after adjustment for individual MetS components. Of the markers of subclinical atherosclerosis, C1 and C2 were negatively and fibrinogen and resting heart rate positively associated with the presence of ED. The association between ED and C1 remained significant after adjustment for age (p = 0.047). OxLDL levels did not associate with the presence of ED.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Univariate analyses of risk factors and markers of CVD as predictors of ED.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Covariates</th><th align="center">OR</th><th align="center">95% CI</th><th align="center">p</th></tr></thead><tbody><tr><td align="left">Age, years</td><td align="center">1.14</td><td align="center">1.066-1.209</td><td align="center">&#x0003c; 0.001</td></tr><tr><td align="left">Smoking, yes/no</td><td align="center">1.16</td><td align="center">0.349-3.871</td><td align="center">NS</td></tr><tr><td align="left">No of pack-years in smokers</td><td align="center">1.06</td><td align="center">1.005-1.116</td><td align="center">0.031</td></tr><tr><td align="left">Metabolic syndrome, yes/no</td><td align="center">4.62</td><td align="center">2.005-10.623</td><td align="center">&#x0003c;0.001</td></tr><tr><td align="left">Diabetes, yes/no</td><td align="center">4.43</td><td align="center">1.666-11.794</td><td align="center">0.003</td></tr><tr><td align="left">Hypertension, yes/no</td><td align="center">3.24</td><td align="center">1.387-7.587</td><td align="center">0.007</td></tr><tr><td align="left">CVD, yes/no</td><td align="center">2.94</td><td align="center">0.718-12.082</td><td align="center">NS</td></tr><tr><td align="left">Family history of CVD, yes/no</td><td align="center">1.14</td><td align="center">0.529-2.466</td><td align="center">NS</td></tr><tr><td align="left">BMI, kg/m<sup>2</sup></td><td align="center">1.11</td><td align="center">1.029-1.200</td><td align="center">0.007</td></tr><tr><td align="left">Physical activity, &#x0003e;400 vs. &#x0003c;200 kcal/day</td><td align="center">0.22</td><td align="center">0.082-0.561</td><td align="center">0.002</td></tr><tr><td align="left">HDL cholesterol, mmol/L</td><td align="center">0.47</td><td align="center">0.177-1.239</td><td align="center">NS</td></tr><tr><td align="left">LDL cholesterol, mmol/L</td><td align="center">0.82</td><td align="center">0.524-1.293</td><td align="center">NS</td></tr><tr><td align="left">Triglycerides, mmol/L</td><td align="center">1.31</td><td align="center">0.948-1.802</td><td align="center">NS</td></tr><tr><td align="left">Heart rate, beats/min</td><td align="center">1.07</td><td align="center">1.026-1.110</td><td align="center">0.001</td></tr><tr><td align="left">Fibrinogen, g/L</td><td align="center">2.83</td><td align="center">1.517-5.274</td><td align="center">0.001</td></tr><tr><td align="left">C1, ml/mmHgx10</td><td align="center">0.88</td><td align="center">0.794-0.969</td><td align="center">0.010</td></tr><tr><td align="left">C2, ml/mmHgx100</td><td align="center">0.87</td><td align="center">0.756-0.993</td><td align="center">0.040</td></tr><tr><td align="left">OxLDL, U/L</td><td align="center">1.00</td><td align="center">0.991-1.016</td><td align="center">NS</td></tr></tbody></table><table-wrap-foot><p>BMI - body mass index; C1 -large arterial elasticity; C2 - small arterial elasticity; CVD - cardiovascular disease; ED - erectile dysfunction; HDL -high density lipoprotein; LDL - low density lipoprotein; OxLDL - oxidized low density lipoprotein</p></table-wrap-foot></table-wrap><p>In the multivariate analysis among all study subjects, age, fibrinogen and resting heart rate were directly and physical activity &#x0003e; 400 kcal/day inversely associated with the presence of ED. These covariates remained significant even after adjustment for traditional CVD risk factors and medications. Results of the adjusted multivariate analysis are presented in Table <xref ref-type="table" rid="T4">4</xref>.</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Significant predictors of ED in the multivariate analysis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Covariates</th><th align="center">OR</th><th align="center">95% CI</th><th align="center">p</th></tr></thead><tbody><tr><td align="left">Age, years</td><td align="center">1.19</td><td align="center">1.072-1.322</td><td align="center">0.001</td></tr><tr><td align="left">Heart rate, beats/min</td><td align="center">1.07</td><td align="center">1.003-1.138</td><td align="center">0.040</td></tr><tr><td align="left">Physical activity, &#x0003e;400 vs. &#x0003c;200 kcal/day</td><td align="center">0.12</td><td align="center">0.017-0.778</td><td align="center">0.027</td></tr><tr><td align="left">Fibrinogen, g/L</td><td align="center">4.67</td><td align="center">1.171-18.627</td><td align="center">0.029</td></tr></tbody></table><table-wrap-foot><p>The model was adjusted for smoking, CVD, diabetes, hypertension, family history of CVD, BMI, HDL and LDL cholesterol, triglycerides and medications. R<sup>2 </sup>= 0.546.</p></table-wrap-foot></table-wrap><p>In the multivariate analysis among MetS subjects only, age (OR 1.23, 95% CI 1.09-1.39, p = 0.001) and fibrinogen (OR 4.30 95% CI 1.21-15.2, p = 0.024) associated directly and physical activity &#x0003e; 400 kcal/day (OR 0.05, 95% CI 0.004-0.65, p = 0.022) inversely with the presence of ED. These covariates were significant predictors of ED even after adjustment for smoking, diabetes, hypertension, CVD, LDL and HDL cholesterol, triglycerides, BMI, family history of CVD, and selective beta-blockers. Among PhA subjects, age was the only significant predictor for the presence of ED (OR 1.16, 95% CI 1.04-1.30, p = 0.008).</p></sec><sec><title>Discussion</title><p>In the present study, physical activity was an independent predictor of normal erectile function, whereas increased fibrinogen and resting heart rate associated independently with erectile dysfunction (ED). Impaired large arterial elasticity (C1) was related to the presence of ED as well as to the presence of MetS. Markers of subclinical atherosclerosis were most evident among subjects with both MetS and ED.</p><p>Previously physical activity has been found to decrease the risk of ED and to improve sexual function among those with established ED [<xref ref-type="bibr" rid="B23">23</xref>-<xref ref-type="bibr" rid="B25">25</xref>]. We found a physical exercise level of &#x0003e; 400 kcal/day (<italic>i.e</italic>. &#x0003e; 2800 kcal/week) to associate independently with normal erectile function in the analyses among all participants as well as in the analyses restricted to MetS subjects only. To our knowledge, this is the first study reporting the positive association between physical activity and the presence of normal erectile function among MetS.</p><p>PhA subjects presented often with normal erectile function, whereas ED was highly prevalent among men with MetS. Although we excluded subjects with submaximal IIEF score (score 26-29), still considered as normal erectile function by the IIEF, the presence of ED among PhA subjects was lower than expected [<xref ref-type="bibr" rid="B26">26</xref>]. Since obesity, smoking and excess alcohol consumption have been reported to associate with ED, and physical activity is protective of ED, the overall healthy behaviour of the PhA subjects must have contributed to the high existence of normal erectile function among them [<xref ref-type="bibr" rid="B23">23</xref>-<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>].</p><p>In a recent study, MetS did not improve prediction of CVD after adjustment for its individual components [<xref ref-type="bibr" rid="B28">28</xref>]. In agreement, MetS <italic>per se </italic>was not an independent predictor of ED in the present study. However, we found a high prevalence of ED among MetS which has also been reported previously [<xref ref-type="bibr" rid="B29">29</xref>]. The prevalence of ED in the presence of diabetes or CVD is known to be even higher [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. Accordingly, there were more diabetics and CVD patients among those with MetS and ED in the present study. Those with ED were also older and more often hypertensive. Although subjects with non-selective &#x003b2;-blocker medication were excluded, ED subjects were more often on selective beta-blockers. These factors may contribute to the higher number of ED among MetS, and thereby to the findings of the study. However, neither diabetes nor CVD were significant predictors of ED in the multivariate analyses of the present study. In addition, although the risk of sexual dysfunction caused by &#x003b2;-blockers was low in a previous systematic review of randomized trials, the results of the present study were adjusted for the use of selective beta-blockers [<xref ref-type="bibr" rid="B31">31</xref>]. Furthermore, also medications reported to improve sexual function were more often used among subjects with MetS and ED [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>]. Thus, the high use of medications among MetS seems rather reflect the physical inactivity, obesity and concomitant diseases among them, whereas the high prevalence of ED among MetS may reflect the presence of underlying, atherosclerotic disease.</p><p>We found increased fibrinogen levels among MetS compared to PhA subjects which agrees with previous studies [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. Physical inactivity, obesity and smoking have been reported to associate with increased fibrinogen levels, and thus may partly explain the difference [<xref ref-type="bibr" rid="B35">35</xref>-<xref ref-type="bibr" rid="B37">37</xref>]. Fibrinogen levels were significantly higher also in the presence of ED compared to the levels in the presence of normal erectile function in the analyses among all participants but also among only MetS subjects. In addition, increased fibrinogen levels associated with the presence of ED independently of multiple other CVD risk factors. There are no previous studies on the association of increased fibrinogen and ED among MetS. However, our finding agrees with a previous study by Vlachopoulos et al [<xref ref-type="bibr" rid="B38">38</xref>] reporting an independent predictive value of fibrinogen for the presence of ED both among men with and without coronary artery disease. Differing from the analyses restricted to MetS subjects only, fibrinogen levels did not associate with the presence of ED among PhA subjects in the present study. The reason may be the small number of ED among them, again reflecting the protective effect of healthy, active lifestyle.</p><p>In line with previous publications we found a decrease in large arterial elasticity (C1) among MetS compared to PhA subjects [<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>]. In addition, impaired C1 associated with the presence of ED. C1 was especially low among men with both MetS and ED. There are also previous reports on the connection between impaired large arterial elasticity and ED [<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>]. However, in these studies arterial elasticity was assessed by ultrasound or pulse-wave velocity measurements, not by the pulse-wave analysis as in our previous and the present study [<xref ref-type="bibr" rid="B43">43</xref>].</p><p>Endothelial dysfunction is believed to be a key mechanism in the pathogenesis of ED as well as of other atherosclerotic cardiovascular diseases [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. In studies assessing endothelial function by a regional measurement of brachial flow-mediated dilation, endothelial dysfunction associated with ED [<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>]. Small arterial elasticity (C2), assessed in the present study, reflects the systemic endothelial function of the microvascular circulation but is also affected by alterations in the elastic properties of the arterial wall [<xref ref-type="bibr" rid="B3">3</xref>]. Since C2 is not a mere measurement of endothelial function, it may explain why the association between C2 and the presence of ED did not remain significant after adjustments.</p><p>Regular aerobic exercise may attenuate age-related reduction in large arterial elasticity [<xref ref-type="bibr" rid="B46">46</xref>] and decrease circulating oxLDL levels [<xref ref-type="bibr" rid="B47">47</xref>]. However, a significant decrease in arterial elasticity and increase in oxidative stress have been reported after exercise at a vigorous level [<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B49">49</xref>]. In our study, large arterial elasticity was better among PhA compared to MetS subjects whereas oxLDL levels were comparable between the groups. The relatively small number of study subjects may explain why the trend of increasing oxLDL in the presence of MetS and ED remained non-significant. In addition, although the inclusion criterion of minimum physical exercise for the PhA subjects was relatively low, the reported high level and intensity of exercise among them might have influenced the results.</p><p>Previously MetS variables, such as hypertension, insulin resistance and obesity, have been reported to associate with adrenergic overdrive [<xref ref-type="bibr" rid="B50">50</xref>]. Accompanying elevation in resting heart rate increases peak blood flow during diastole which in turn enhances pulsatile and shear stress on the endothelium [<xref ref-type="bibr" rid="B51">51</xref>]. Resulting endothelial dysfunction and loss of arterial elasticity may explain the connection between elevated resting heart rate and ED [<xref ref-type="bibr" rid="B51">51</xref>,<xref ref-type="bibr" rid="B52">52</xref>]. In agreement, resting heart rate was higher among MetS compared to PhA subjects in the present study, despite the higher use of beta-blockers among MetS. In addition, heart rate was higher among ED compared to non-ED subjects, being highest among men with both MetS and ED. Since MetS subjects with ED were physically most inactive, the elevated resting heart rate was at least partly a consequence of their physical unfitness. However, elevated resting heart rate predicted the presence of ED independently of physical activity, multiple other CVD risk factors, and beta-blocker medication.</p><p>Because of the cross-sectional design, we cannot make assumptions on the linkage between the markers of subclinical CVD and true CVD risk in the future. However, the present study provides possible pathophysiological links between erectile dysfunction and increased cardiovascular risk among MetS. Subjects with MetS are known to be at high risk for CVD [<xref ref-type="bibr" rid="B15">15</xref>]. ED, on its part, is considered as an early clinical manifestation of systemic atherosclerosis [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. Markers of subclinical atherosclerosis, assessed in the present study, have previously been reported to associate with increased risk of CVD events and mortality [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. Since increased fibrinogen and elevated resting heart rate as well as impaired arterial elasticity were present among MetS compared to PhA subjects, as well as among ED compared to non-ED subjects, they may partly explain the increased CVD risk associated both with MetS and with ED. Since these markers of subclinical atherosclerosis were most evident among subjects with both MetS and ED, especially these patients should be considered at high cardiovascular risk.</p><p>One mechanism linking MetS to ED is believed to be hypogonadism associated with visceral obesity [<xref ref-type="bibr" rid="B53">53</xref>]. In addition, physical activity may partly intermediate its benefits through an induced increase in testosterone levels [<xref ref-type="bibr" rid="B54">54</xref>]. Another possible pathophysiologic linkage between MetS and ED is subclinical inflammation [<xref ref-type="bibr" rid="B55">55</xref>]. We did not assess testosterone or CRP levels which was a limitation of the study.</p><p>IIEF questionnaire is a reliable method to assess the presence and severity of ED [<xref ref-type="bibr" rid="B56">56</xref>]. In our study, number of subjects reported lack of sexual activity and thus were unable to answer the IIEF questions concerning erectile function during intercourse. Among them, we used a single-question assessment of ED. Although the single-question assessment has been found to properly identify men with ED [<xref ref-type="bibr" rid="B57">57</xref>], we wanted to be sure that subjects participating in the study truly had either completely normal erectile function or real ED. Therefore, we accepted only men with either full score or score &#x02264;25 in the six-question IIEF or men with full score or score &#x02264;3 in the single-question assessment to participate in the study. Because of the relatively small number of study subjects and the fact that a single-question assessment of ED was used among subjects without previous sexual activity, we could not study the effects of severity of ED.</p></sec><sec><title>Conclusions</title><p>Increased fibrinogen and resting heart rate as well as impaired arterial elasticity associated with the presence of ED and were most evident among subjects with both MetS and ED. Physical exercise, on its part, was a strong and independent predictor of normal erectile function among all as well as among only MetS subjects. Thus, especially MetS patients presenting with ED should be considered at high risk for CVD. In addition, our findings support the importance of physical exercise in the management of MetS and concomitant diseases.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>AP designed the study. HPM and AP participated in the acquisition and analysis of the data. HPM, AP and JH participated in the drafting of the manuscript. All authors have approved the final manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2261/11/36/prepub">http://www.biomedcentral.com/1471-2261/11/36/prepub</ext-link></p></sec></body><back><sec><title>Acknowledgements and Funding</title><p>We sincerely acknowledge Kalevi Oksanen, P&#x000e4;ivi Kankkunen, Paula Lahtinen, Kirsti Inkil&#x000e4;, Annika Palom&#x000e4;ki, Sanna Haavisto and Outi Vanha-K&#x000e4;mpp&#x000e4; for their professional technical aid. The authors gratefully acknowledge the co-operation of the study subjects.</p><p>The study was supported by grants from the Ministry of Health and Social Welfare in Finland through the Medical Research Fund of Kanta-H&#x000e4;me Central Hospital, the H&#x000e4;me and Pohjois-Savo Regional Funds under the auspices of the Finnish Cultural Foundation, and Oy Eli Lilly Finland Ab. None of them had a role in data collection, analysis of the results, or preparation of the manuscript.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Stocker</surname><given-names>R</given-names></name><name><surname>Keaney</surname><given-names>JF</given-names><suffix>Jr</suffix></name><article-title>Role of oxidative modifications in atherosclerosis</article-title><source>Physiol Rev</source><year>2004</year><volume>84</volume><fpage>1381</fpage><lpage>1478</lpage><pub-id pub-id-type="doi">10.1152/physrev.00047.2003</pub-id><pub-id pub-id-type="pmid">15383655</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Kirby</surname><given-names>M</given-names></name><name><surname>Jackson</surname><given-names>G</given-names></name><name><surname>Simonsen</surname><given-names>U</given-names></name><article-title>Endothelial dysfunction links erectile dysfunction to heart Disease</article-title><source>Int J Clin Pract</source><year>2005</year><volume>59</volume><fpage>225</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1111/j.1742-1241.2005.00453.x</pub-id><pub-id pub-id-type="pmid">15854201</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Cohn</surname><given-names>J</given-names></name><name><surname>Finkelstein</surname><given-names>S</given-names></name><name><surname>McVeigh</surname><given-names>G</given-names></name><name><surname>Morgan</surname><given-names>D</given-names></name><name><surname>LeMay</surname><given-names>L</given-names></name><name><surname>Robinson</surname><given-names>J</given-names></name><name><surname>Mock</surname><given-names>J</given-names></name><article-title>Non-invasive Pulse Wave Analysis for the Early Detection of Vascular Disease</article-title><source>Hypertension</source><year>1995</year><volume>26</volume><fpage>503</fpage><lpage>508</lpage><pub-id pub-id-type="pmid">7649589</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Boutouyrie</surname><given-names>P</given-names></name><name><surname>Tropeano</surname><given-names>I</given-names></name><name><surname>Asmar</surname><given-names>R</given-names></name><name><surname>Gautier</surname><given-names>I</given-names></name><name><surname>Benetos</surname><given-names>A</given-names></name><name><surname>Lacolley</surname><given-names>P</given-names></name><name><surname>Laurent</surname><given-names>S</given-names></name><article-title>Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients. A longitudinal study</article-title><source>Hypertension</source><year>2002</year><volume>39</volume><fpage>10</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1161/hy0102.099031</pub-id><pub-id pub-id-type="pmid">11799071</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Van Popele</surname><given-names>N</given-names></name><name><surname>Grobbee</surname><given-names>D</given-names></name><name><surname>Bots</surname><given-names>M</given-names></name><name><surname>Asmar</surname><given-names>R</given-names></name><name><surname>Topouchian</surname><given-names>J</given-names></name><name><surname>Reneman</surname><given-names>R</given-names></name><name><surname>Hoeks</surname><given-names>A</given-names></name><name><surname>Van der Kuip</surname><given-names>D</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Witteman</surname><given-names>J</given-names></name><article-title>Association between arterial stiffness and atherosclerosis. The Rotterdam study</article-title><source>Stroke</source><year>2001</year><volume>32</volume><fpage>454</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1161/01.STR.32.2.454</pub-id><pub-id pub-id-type="pmid">11157182</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Holvoet</surname><given-names>P</given-names></name><name><surname>Mertens</surname><given-names>A</given-names></name><name><surname>Verhamme</surname><given-names>P</given-names></name><name><surname>Bogaerts</surname><given-names>K</given-names></name><name><surname>Beyens</surname><given-names>G</given-names></name><name><surname>Verhaeghe</surname><given-names>R</given-names></name><name><surname>Collen</surname><given-names>D</given-names></name><name><surname>Muls</surname><given-names>E</given-names></name><name><surname>Van de Werf</surname><given-names>F</given-names></name><article-title>Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2001</year><volume>21</volume><fpage>844</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.21.5.844</pub-id><pub-id pub-id-type="pmid">11348884</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><collab>Fibrinogen Studies Collaboration</collab><article-title>Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis</article-title><source>JAMA</source><year>2005</year><volume>294</volume><fpage>1799</fpage><lpage>1809</lpage><pub-id pub-id-type="pmid">16219884</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Cooney</surname><given-names>M</given-names></name><name><surname>Vartiainen</surname><given-names>E</given-names></name><name><surname>Laatikainen</surname><given-names>T</given-names></name><name><surname>Juolevi</surname><given-names>A</given-names></name><name><surname>Dudina</surname><given-names>A</given-names></name><name><surname>Graham</surname><given-names>I</given-names></name><article-title>Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women</article-title><source>Am Heart J</source><year>2010</year><volume>159</volume><fpage>612</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2009.12.029</pub-id><pub-id pub-id-type="pmid">20362720</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Jackson</surname><given-names>G</given-names></name><name><surname>Boon</surname><given-names>N</given-names></name><name><surname>Eardley</surname><given-names>I</given-names></name><name><surname>Kirby</surname><given-names>M</given-names></name><name><surname>Dean</surname><given-names>J</given-names></name><name><surname>Hackett</surname><given-names>G</given-names></name><name><surname>Montorsi</surname><given-names>P</given-names></name><name><surname>Montorsi</surname><given-names>F</given-names></name><name><surname>Vlachopoulos</surname><given-names>C</given-names></name><name><surname>Kloner</surname><given-names>R</given-names></name><name><surname>Sharlip</surname><given-names>I</given-names></name><name><surname>Miner</surname><given-names>M</given-names></name><article-title>Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus</article-title><source>Int J Clin Pract</source><year>2010</year><volume>64</volume><fpage>848</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1111/j.1742-1241.2010.02410.x</pub-id><pub-id pub-id-type="pmid">20584218</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Thompson</surname><given-names>I</given-names></name><name><surname>Tangen</surname><given-names>C</given-names></name><name><surname>Goodman</surname><given-names>P</given-names></name><name><surname>Probstfield</surname><given-names>J</given-names></name><name><surname>Moinpour</surname><given-names>C</given-names></name><name><surname>Coltman</surname><given-names>C</given-names></name><article-title>Erectile dysfunction and subsequent cardiovascular disease</article-title><source>JAMA</source><year>2005</year><volume>294</volume><fpage>2996</fpage><lpage>3002</lpage><pub-id pub-id-type="doi">10.1001/jama.294.23.2996</pub-id><pub-id pub-id-type="pmid">16414947</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Inman</surname><given-names>B</given-names></name><name><surname>Sauver</surname><given-names>J</given-names></name><name><surname>Jacobson</surname><given-names>D</given-names></name><name><surname>McGree</surname><given-names>M</given-names></name><name><surname>Nehra</surname><given-names>A</given-names></name><name><surname>Lieber</surname><given-names>M</given-names></name><name><surname>Roger</surname><given-names>V</given-names></name><name><surname>Jacobsen</surname><given-names>S</given-names></name><article-title>A population-based, longitudinal study of erectile dysfunction and future coronary artery disease</article-title><source>Mayo Clin Proc</source><year>2009</year><volume>84</volume><fpage>108</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.4065/84.2.108</pub-id><pub-id pub-id-type="pmid">19181643</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Araujo</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>S</given-names></name><name><surname>Ganz</surname><given-names>P</given-names></name><name><surname>Chiu</surname><given-names>G</given-names></name><name><surname>Rosen</surname><given-names>R</given-names></name><name><surname>Kupelian</surname><given-names>V</given-names></name><name><surname>Travison</surname><given-names>T</given-names></name><name><surname>McKinlay</surname><given-names>J</given-names></name><article-title>Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score</article-title><source>J Am Coll Cardiol</source><year>2010</year><volume>55</volume><fpage>350</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2009.08.058</pub-id><pub-id pub-id-type="pmid">20117441</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Montorsi</surname><given-names>P</given-names></name><name><surname>Ravagnani</surname><given-names>PM</given-names></name><name><surname>Galli</surname><given-names>S</given-names></name><name><surname>Rotatori</surname><given-names>F</given-names></name><name><surname>Briganti</surname><given-names>A</given-names></name><name><surname>Salonia</surname><given-names>A</given-names></name><name><surname>Rigatti</surname><given-names>P</given-names></name><name><surname>Montorsi</surname><given-names>F</given-names></name><article-title>The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease</article-title><source>Am J Cardiol</source><year>2005</year><volume>96</volume><issue>Suppl</issue><fpage>19M</fpage><lpage>23M</lpage><pub-id pub-id-type="pmid">16387561</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Sisson</surname><given-names>SB</given-names></name><name><surname>Camhi</surname><given-names>SM</given-names></name><name><surname>Church</surname><given-names>TS</given-names></name><name><surname>Martin</surname><given-names>CK</given-names></name><name><surname>Tudor-Locke</surname><given-names>C</given-names></name><name><surname>Bouchard</surname><given-names>C</given-names></name><name><surname>Earnest</surname><given-names>CP</given-names></name><name><surname>Smith</surname><given-names>SR</given-names></name><name><surname>Newton</surname><given-names> RL</given-names><suffix>Jr</suffix></name><name><surname>Rankinen</surname><given-names>T</given-names></name><name><surname>Katzmarzyk</surname><given-names>PT</given-names></name><article-title>Leisure time sedentary behaviour, occupational/domestic physical activity and metabolic syndrome in U.S. men and women</article-title><source>Metab Syndr Relat Disord</source><year>2009</year><volume>7</volume><fpage>529</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1089/met.2009.0023</pub-id><pub-id pub-id-type="pmid">19900152</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Hu</surname><given-names>G</given-names></name><name><surname>Qiao</surname><given-names>Q</given-names></name><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Borch-Johnsen</surname><given-names>K</given-names></name><name><surname>Pyorala</surname><given-names>K</given-names></name><collab>for the DECODE study group</collab><article-title>Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women</article-title><source>Arch Intern Med</source><year>2004</year><volume>164</volume><fpage>1066</fpage><lpage>1067</lpage><pub-id pub-id-type="doi">10.1001/archinte.164.10.1066</pub-id><pub-id pub-id-type="pmid">15159263</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><collab>Third report of the National Cholesterol Education Program (NCEP) expert panel on</collab><article-title>detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Final report</article-title><source>Circulation</source><year>2002</year><volume>106</volume><fpage>3143</fpage><lpage>3421</lpage><pub-id pub-id-type="pmid">12485966</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Ainsworth</surname><given-names>B</given-names></name><name><surname>Haskell</surname><given-names>W</given-names></name><name><surname>Whitt</surname><given-names>M</given-names></name><name><surname>Irwin</surname><given-names>M</given-names></name><name><surname>Swartz</surname><given-names>A</given-names></name><name><surname>Strath</surname><given-names>S</given-names></name><name><surname>O'Brien</surname><given-names>W</given-names></name><name><surname>Basset</surname><given-names>D</given-names></name><name><surname>Schmitz</surname><given-names>K</given-names></name><name><surname>Emplaincourt</surname><given-names>P</given-names></name><name><surname>Jacobs</surname><given-names>D</given-names></name><name><surname>Leon</surname><given-names>A</given-names></name><article-title>Compendium of physical activities: an update of activity codes and MET intensities</article-title><source>Med Sci Sports Exerc</source><year>2000</year><volume>32</volume><fpage>498</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1097/00005768-200009001-00009</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Rosen</surname><given-names>R</given-names></name><name><surname>Riley</surname><given-names>A</given-names></name><name><surname>Wagner</surname><given-names>G</given-names></name><name><surname>Osterloh</surname><given-names>I</given-names></name><name><surname>Kirkpatrick</surname><given-names>J</given-names></name><name><surname>Mishra</surname><given-names>A</given-names></name><article-title>The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction</article-title><source>Urology</source><year>1997</year><volume>6</volume><fpage>822</fpage><lpage>830</lpage></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Prisant</surname><given-names>LM</given-names></name><name><surname>Pasi</surname><given-names>M</given-names></name><name><surname>Jupin</surname><given-names>D</given-names></name><name><surname>Prisant</surname><given-names>ME</given-names></name><article-title>Assessment of repeatability and correlates of arterial compliance</article-title><source>Blood Press Monit</source><year>2000</year><volume>7</volume><fpage>231</fpage><lpage>235</lpage></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Resnick</surname><given-names>LM</given-names></name><name><surname>Militianu</surname><given-names>D</given-names></name><name><surname>Cunnings</surname><given-names>AJ</given-names></name><name><surname>Pipe</surname><given-names>JG</given-names></name><name><surname>Evelhoch</surname><given-names>JL</given-names></name><name><surname>Soulen</surname><given-names>RL</given-names></name><name><surname>Lester</surname><given-names>MA</given-names></name><article-title>Pulse waveform analysis of arterial compliance: relation to other techniques, age, and metabolic variables</article-title><source>Am J Hypertens</source><year>2000</year><volume>13</volume><fpage>1243</fpage><lpage>1249</lpage><pub-id pub-id-type="doi">10.1016/S0895-7061(00)01219-X</pub-id><pub-id pub-id-type="pmid">11130766</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Wilson</surname><given-names>AM</given-names></name><name><surname>O'Neal</surname><given-names>D</given-names></name><name><surname>Nelson</surname><given-names>CL</given-names></name><name><surname>Prior</surname><given-names>DL</given-names></name><name><surname>Best</surname><given-names>JD</given-names></name><name><surname>Jenkins</surname><given-names>AJ</given-names></name><article-title>Comparison of arterial assessments in low and high vascular disease groups</article-title><source>Am J Hypertens</source><year>2004</year><volume>17</volume><fpage>285</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1016/j.amjhyper.2003.10.009</pub-id><pub-id pub-id-type="pmid">15062880</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Zimlichman</surname><given-names>R</given-names></name><name><surname>Shargorodsky</surname><given-names>M</given-names></name><name><surname>Boaz</surname><given-names>M</given-names></name><name><surname>Duprez</surname><given-names>D</given-names></name><name><surname>Rahn</surname><given-names>KH</given-names></name><name><surname>Rizzoni</surname><given-names>D</given-names></name><name><surname>Payeras</surname><given-names>AC</given-names></name><name><surname>Hamm</surname><given-names>C</given-names></name><name><surname>McVeigh</surname><given-names>G</given-names></name><article-title>Determination of arterial compliance using blood pressure waveform analysis with the CR-2000 system: reliability, repeatability, and establishment of normal values for healthy European population - the seven European sites study (SESS)</article-title><source>Am J Hypertens</source><year>2005</year><volume>18</volume><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">15691619</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Bacon</surname><given-names>CG</given-names></name><name><surname>Mittleman</surname><given-names>MA</given-names></name><name><surname>Kawachi</surname><given-names>I</given-names></name><name><surname>Giovannucci</surname><given-names>E</given-names></name><name><surname>Glasser</surname><given-names>DB</given-names></name><name><surname>Rimm</surname><given-names>EB</given-names></name><article-title>A prospective study of risk factors for erectile dysfunction</article-title><source>J Urol</source><year>2006</year><volume>176</volume><fpage>217</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/S0022-5347(06)00589-1</pub-id><pub-id pub-id-type="pmid">16753404</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Kratzik</surname><given-names>CW</given-names></name><name><surname>Lackner</surname><given-names>JE</given-names></name><name><surname>M&#x000e4;rk</surname><given-names>I</given-names></name><name><surname>R&#x000fc;cklinger</surname><given-names>E</given-names></name><name><surname>Schmidbauer</surname><given-names>J</given-names></name><name><surname>Lunglmayr</surname><given-names>G</given-names></name><name><surname>Schatzl</surname><given-names>G</given-names></name><article-title>How much physical activity is needed to maintain erectile function? Results of The Androx Vienna Municipality study</article-title><source>Eur Urol</source><year>2009</year><volume>55</volume><fpage>509</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2008.02.020</pub-id><pub-id pub-id-type="pmid">18359146</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Esposito</surname><given-names>K</given-names></name><name><surname>Giugliano</surname><given-names>F</given-names></name><name><surname>Di Palo</surname><given-names>C</given-names></name><name><surname>Giugliano</surname><given-names>G</given-names></name><name><surname>Marfella</surname><given-names>R</given-names></name><name><surname>D'Andrea</surname><given-names>F</given-names></name><name><surname>D'Armiento</surname><given-names>M</given-names></name><name><surname>Giugliano</surname><given-names>D</given-names></name><article-title>Effect of lifestyle changes on erectile dysfunction in obese men. A randomized controlled trial</article-title><source>JAMA</source><year>2004</year><volume>291</volume><fpage>2978</fpage><lpage>2984</lpage><pub-id pub-id-type="doi">10.1001/jama.291.24.2978</pub-id><pub-id pub-id-type="pmid">15213209</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Teles</surname><given-names>AG</given-names></name><name><surname>Carreira</surname><given-names>M</given-names></name><name><surname>Alarc&#x000e3;o</surname><given-names>V</given-names></name><name><surname>Sociol</surname><given-names>D</given-names></name><name><surname>Arag&#x000fc;&#x000e9;s</surname><given-names>JM</given-names></name><name><surname>Lopes</surname><given-names>L</given-names></name><name><surname>Mascarenhas</surname><given-names>M</given-names></name><name><surname>Costa</surname><given-names>JG</given-names></name><article-title>Prevalence, severity, and risk factors for erectile dysfunction in a representative sample of 3,548 Portuguese men aged 40 to 69 years attending primary healthcare centers: results of the Portuguese erectile dysfunction study</article-title><source>J Sex Med</source><year>2008</year><volume>5</volume><fpage>1317</fpage><lpage>1324</lpage><pub-id pub-id-type="doi">10.1111/j.1743-6109.2007.00745.x</pub-id><pub-id pub-id-type="pmid">18194181</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="other"><name><surname>Christensen</surname><given-names>BS</given-names></name><name><surname>Gr&#x000f8;nbaek</surname><given-names>M</given-names></name><name><surname>Pedersen</surname><given-names>BV</given-names></name><name><surname>Graugaard</surname><given-names>C</given-names></name><name><surname>Frisch</surname><given-names>M</given-names></name><name><surname>Horansanli</surname><given-names>K</given-names></name><name><surname>Boylu</surname><given-names>U</given-names></name><name><surname>Kendirci</surname><given-names>M</given-names></name><name><surname>Miroglu</surname><given-names>C</given-names></name><article-title>Associations of unhealthy lifestyle factors with sexual inactivity and sexual dysfunctions in Denmark</article-title><source>J Sex Med</source><year>2011</year><comment> in press </comment></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="other"><name><surname>Hadaegh</surname><given-names>F</given-names></name><name><surname>Zabetian</surname><given-names>A</given-names></name><name><surname>Khalili</surname><given-names>D</given-names></name><name><surname>Safarkhani</surname><given-names>M</given-names></name><name><surname>James</surname><given-names>WP</given-names></name><name><surname>Azizi</surname><given-names>F</given-names></name><article-title>A new approach to compare the predictive power of metabolic syndrome defined by a joint interim statement versus its components for incident cardiovascular disease in Middle East Caucasian residents in Tehran</article-title><source>J Epidemiol Community Health</source><year>2010</year><comment> in press </comment></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Bal</surname><given-names>K</given-names></name><name><surname>&#x000d6;der</surname><given-names>M</given-names></name><name><surname>&#x0015e;ahin</surname><given-names>A</given-names></name><name><surname>Karata&#x0015f;</surname><given-names>C</given-names></name><name><surname>Demir</surname><given-names>&#x000d6;</given-names></name><name><surname>Can</surname><given-names>E</given-names></name><name><surname>G&#x000fc;m&#x000fc;&#x0015f;</surname><given-names>B</given-names></name><name><surname>&#x000d6;zer</surname><given-names>K</given-names></name><name><surname>&#x0015e;ahin</surname><given-names>O</given-names></name><name><surname>Esen</surname><given-names>A</given-names></name><article-title>Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: metabolic backgrounds of erectile dysfunction</article-title><source>Urology</source><year>2007</year><volume>69</volume><fpage>356</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1016/j.urology.2006.09.057</pub-id><pub-id pub-id-type="pmid">17275074</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Selvin</surname><given-names>E</given-names></name><name><surname>Burnett</surname><given-names>AL</given-names></name><name><surname>Platz</surname><given-names>EA</given-names></name><article-title>Prevalence and risk factors for erectile dysfunction in the US</article-title><source>Am J Med</source><year>2007</year><volume>120</volume><fpage>151</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.amjmed.2006.06.010</pub-id><pub-id pub-id-type="pmid">17275456</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Ko</surname><given-names>DT</given-names></name><name><surname>Hebert</surname><given-names>PR</given-names></name><name><surname>Coffey</surname><given-names>CS</given-names></name><name><surname>Sedrakyan</surname><given-names>A</given-names></name><name><surname>Curtis</surname><given-names>JP</given-names></name><name><surname>Krumholz</surname><given-names>HM</given-names></name><article-title>Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction</article-title><source>JAMA</source><year>2002</year><volume>288</volume><fpage>351</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1001/jama.288.3.351</pub-id><pub-id pub-id-type="pmid">12117400</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>D&#x000fc;sing</surname><given-names>R</given-names></name><article-title>Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men</article-title><source>Blood Press Suppl</source><year>2003</year><volume>2</volume><fpage>29</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">14761074</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Do&#x0011f;ru</surname><given-names>MT</given-names></name><name><surname>Ba&#x0015f;ar</surname><given-names>MM</given-names></name><name><surname>Sim&#x0015f;ek</surname><given-names>A</given-names></name><name><surname>Yuvan&#x000e7;</surname><given-names>E</given-names></name><name><surname>G&#x000fc;neri</surname><given-names>M</given-names></name><name><surname>Ebin&#x000e7;</surname><given-names>H</given-names></name><name><surname>Batislam</surname><given-names>E</given-names></name><article-title>Effects of statin treatment on serum sex steroids levels and autonomic and erectile function</article-title><source>Urology</source><year>2008</year><volume>71</volume><fpage>703</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1016/j.urology.2007.11.059</pub-id><pub-id pub-id-type="pmid">18387399</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Ford</surname><given-names>ES</given-names></name><article-title>The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey</article-title><source>Atherosclerosis</source><year>2003</year><volume>168</volume><fpage>351</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1016/S0021-9150(03)00134-5</pub-id><pub-id pub-id-type="pmid">12801619</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Church</surname><given-names>TS</given-names></name><name><surname>Finley</surname><given-names>CE</given-names></name><name><surname>Earnest</surname><given-names>CP</given-names></name><name><surname>Kampert</surname><given-names>JB</given-names></name><name><surname>Gibbons</surname><given-names>LW</given-names></name><name><surname>Blair</surname><given-names>SN</given-names></name><article-title>Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome</article-title><source>Int J Obes</source><year>2002</year><volume>26</volume><fpage>805</fpage><lpage>813</lpage></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Myint</surname><given-names>PK</given-names></name><name><surname>Luben</surname><given-names>RN</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Welch</surname><given-names>AA</given-names></name><name><surname>Bingham</surname><given-names>SA</given-names></name><name><surname>Khaw</surname><given-names>KT</given-names></name><article-title>Physical activity and fibrinogen concentrations in 23,201 men and women in the EPIC-Norfolk population-based study</article-title><source>Atherosclerosis</source><year>2008</year><volume>198</volume><fpage>419</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2007.09.021</pub-id><pub-id pub-id-type="pmid">17977548</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Sinha</surname><given-names>S</given-names></name><name><surname>Luben</surname><given-names>RN</given-names></name><name><surname>Welch</surname><given-names>A</given-names></name><name><surname>Bingham</surname><given-names>S</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Day</surname><given-names>NE</given-names></name><name><surname>Khaw</surname><given-names>KT</given-names></name><article-title>Fibrinogen and cigarette smoking in men and women in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2005</year><volume>12</volume><fpage>144</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">15785300</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Vlachopoulos</surname><given-names>C</given-names></name><name><surname>Aznaouridis</surname><given-names>K</given-names></name><name><surname>Ioakeimidis</surname><given-names>N</given-names></name><name><surname>Rokkas</surname><given-names>K</given-names></name><name><surname>Vasiliadou</surname><given-names>C</given-names></name><name><surname>Alexopoulos</surname><given-names>N</given-names></name><name><surname>Stefanadi</surname><given-names>E</given-names></name><name><surname>Askitis</surname><given-names>A</given-names></name><name><surname>Stefanadis</surname><given-names>C</given-names></name><article-title>Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease</article-title><source>Eur Heart J</source><year>2006</year><volume>27</volume><fpage>2640</fpage><lpage>2648</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehl341</pub-id><pub-id pub-id-type="pmid">17056702</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Pohjant&#x000e4;hti-Maaroos</surname><given-names>H</given-names></name><name><surname>Palom&#x000e4;ki</surname><given-names>A</given-names></name><name><surname>Kankkunen</surname><given-names>P</given-names></name><name><surname>Laitinen</surname><given-names>R</given-names></name><name><surname>Husgafvel</surname><given-names>S</given-names></name><name><surname>Oksanen</surname><given-names>K</given-names></name><article-title>Circulating oxidized low-density lipoproteins and arterial elasticity: comparison between men with metabolic syndrome and physically active counterparts</article-title><source>Cardiovasc Diabetol</source><year>2010</year><volume>9</volume><fpage>41</fpage><pub-id pub-id-type="doi">10.1186/1475-2840-9-41</pub-id><pub-id pub-id-type="pmid">20727144</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Ge</surname><given-names>JY</given-names></name><name><surname>Li</surname><given-names>XL</given-names></name><name><surname>Zhang</surname><given-names>HF</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Tong</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>JG</given-names></name><article-title>Elasticity indices of large and small arteries in relation to the metabolic syndrome in Chinese</article-title><source>Am J Hypertens</source><year>2008</year><volume>21</volume><fpage>143</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1038/ajh.2007.26</pub-id><pub-id pub-id-type="pmid">18188165</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Kaya</surname><given-names>C</given-names></name><name><surname>Ergelen</surname><given-names>M</given-names></name><name><surname>Ilktac</surname><given-names>A</given-names></name><name><surname>Karaman</surname><given-names>I</given-names></name><article-title>Impaired elasticity of aorta in patients with erectile dysfunction</article-title><source>Urology</source><year>2007</year><volume>70</volume><fpage>558</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1016/j.urology.2007.04.018</pub-id><pub-id pub-id-type="pmid">17688916</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Vlachopoulos</surname><given-names>C</given-names></name><name><surname>Aznaouridis</surname><given-names>K</given-names></name><name><surname>Ioakeimidis</surname><given-names>N</given-names></name><name><surname>Rokkas</surname><given-names>K</given-names></name><name><surname>Tsekoura</surname><given-names>D</given-names></name><name><surname>Vasiliadou</surname><given-names>C</given-names></name><name><surname>Stefanadi</surname><given-names>E</given-names></name><name><surname>Askitis</surname><given-names>A</given-names></name><name><surname>Stefanadis</surname><given-names>C</given-names></name><article-title>Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction</article-title><source>J Hypertens</source><year>2008</year><volume>26</volume><fpage>1829</fpage><lpage>1836</lpage><pub-id pub-id-type="doi">10.1097/HJH.0b013e3283050886</pub-id><pub-id pub-id-type="pmid">18698219</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Pohjant&#x000e4;hti-Maaroos</surname><given-names>H</given-names></name><name><surname>Palom&#x000e4;ki</surname><given-names>A</given-names></name><article-title>Comparison of metabolic syndrome subjects with and without erectile dysfunction - levels of circulating oxidised LDL and arterial elasticity</article-title><source>Int J Clin Pract</source><year>2011</year><volume>65</volume><fpage>274</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1111/j.1742-1241.2010.02595.x</pub-id><pub-id pub-id-type="pmid">21314864</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><name><surname>Kaiser</surname><given-names>D</given-names></name><name><surname>Billups</surname><given-names>K</given-names></name><name><surname>Mason</surname><given-names>C</given-names></name><name><surname>Wetterling</surname><given-names>R</given-names></name><name><surname>Lundberg</surname><given-names>J</given-names></name><name><surname>Bank</surname><given-names>A</given-names></name><article-title>Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease</article-title><source>J Am Coll Cardiol</source><year>2004</year><volume>43</volume><fpage>179</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2003.07.042</pub-id><pub-id pub-id-type="pmid">14736434</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Yavuzgil</surname><given-names>O</given-names></name><name><surname>Altay</surname><given-names>B</given-names></name><name><surname>Zoghi</surname><given-names>M</given-names></name><name><surname>G&#x000fc;rg&#x000fc;n</surname><given-names>C</given-names></name><name><surname>Kay&#x00131;k&#x000e7;&#x00131;o&#x0011f;lu</surname><given-names>M</given-names></name><name><surname>K&#x000fc;lt&#x000fc;rsay</surname><given-names>H</given-names></name><article-title>Endothelial function in patients with vasculogenic erectile dysfunction</article-title><source>Int J Cardiol</source><year>2005</year><volume>103</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2004.07.004</pub-id><pub-id pub-id-type="pmid">16061118</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><name><surname>Sugawara</surname><given-names>J</given-names></name><name><surname>Inoue</surname><given-names>H</given-names></name><name><surname>Haysashi</surname><given-names>K</given-names></name><name><surname>Yokoi</surname><given-names>T</given-names></name><name><surname>Kono</surname><given-names>I</given-names></name><article-title>Effect of low-intensity aerobic exercise training on arterial compliance in postmenopausal women</article-title><source>Hypertens Res</source><year>2004</year><volume>27</volume><fpage>897</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1291/hypres.27.897</pub-id><pub-id pub-id-type="pmid">15894828</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>Elosua</surname><given-names>R</given-names></name><name><surname>Molina</surname><given-names>L</given-names></name><name><surname>Fito</surname><given-names>M</given-names></name><name><surname>Arquer</surname><given-names>A</given-names></name><name><surname>Sanchez-Quesada</surname><given-names>JL</given-names></name><name><surname>Covas</surname><given-names>MI</given-names></name><name><surname>Ordonez-Llanos</surname><given-names>J</given-names></name><name><surname>Marrugat</surname><given-names>J</given-names></name><article-title>Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women</article-title><source>Atherosclerosis</source><year>2003</year><volume>167</volume><fpage>327</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/S0021-9150(03)00018-2</pub-id><pub-id pub-id-type="pmid">12818416</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><name><surname>Miyachi</surname><given-names>M</given-names></name><name><surname>Kawano</surname><given-names>H</given-names></name><name><surname>Sugawara</surname><given-names>J</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Yamazaki</surname><given-names>K</given-names></name><name><surname>Tabata</surname><given-names>I</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><article-title>Unfavorable effects of resistance training on central arterial compliance. A randomized intervention study</article-title><source>Circulation</source><year>2004</year><volume>110</volume><fpage>2858</fpage><lpage>2863</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000146380.08401.99</pub-id><pub-id pub-id-type="pmid">15492301</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><name><surname>Mu&#x000f1;oz</surname><given-names>MD</given-names></name><name><surname>Olcina</surname><given-names>G</given-names></name><name><surname>Tim&#x000f3;n</surname><given-names>R</given-names></name><name><surname>Robles</surname><given-names>MC</given-names></name><name><surname>Caballero</surname><given-names>MJ</given-names></name><name><surname>Maynar</surname><given-names>M</given-names></name><article-title>Effect of different exercise intensities on oxidative stress markers and antioxidant response in trained cyclists</article-title><source>J Sports Med Phys Fitness</source><year>2010</year><volume>50</volume><fpage>93</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">20308979</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><name><surname>Mancia</surname><given-names>G</given-names></name><name><surname>Bousquet</surname><given-names>P</given-names></name><name><surname>Elghozi</surname><given-names>JL</given-names></name><name><surname>Esler</surname><given-names>M</given-names></name><name><surname>Grassi</surname><given-names>G</given-names></name><name><surname>Julius</surname><given-names>S</given-names></name><name><surname>Reid</surname><given-names>J</given-names></name><name><surname>Van Zwieten</surname><given-names>PA</given-names></name><article-title>The sympathetic nervous system and the metabolic syndrome</article-title><source>J Hypertens</source><year>2007</year><volume>25</volume><fpage>909</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1097/HJH.0b013e328048d004</pub-id><pub-id pub-id-type="pmid">17414649</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><name><surname>Arnold</surname><given-names>JM</given-names></name><name><surname>Fitchett</surname><given-names>DH</given-names></name><name><surname>Howlett</surname><given-names>JG</given-names></name><name><surname>Lonn</surname><given-names>EM</given-names></name><name><surname>Tardif</surname><given-names>JC</given-names></name><article-title>Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?</article-title><source>Can J Cardiol</source><year>2008</year><volume>24</volume><issue>SupplA</issue><fpage>3A</fpage><lpage>8A</lpage><pub-id pub-id-type="pmid">18437251</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><name><surname>Tomiyama</surname><given-names>H</given-names></name><name><surname>Hashimoto</surname><given-names>H</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Matsumoto</surname><given-names>C</given-names></name><name><surname>Odaira</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>J</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Shiina</surname><given-names>K</given-names></name><name><surname>Nagata</surname><given-names>M</given-names></name><name><surname>Yamashina</surname><given-names>A</given-names></name><collab>baPWV/cfPWV Collaboration Group</collab><article-title>Synergistic relationship between changes in the pulse wave velocity and changes in the heart rate in middle-aged Japanese adults: a prospective study</article-title><source>J Hypertens</source><year>2010</year><volume>28</volume><fpage>687</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1097/HJH.0b013e3283369fe8</pub-id><pub-id pub-id-type="pmid">20051904</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><name><surname>Corona</surname><given-names>G</given-names></name><name><surname>Mannucci</surname><given-names>E</given-names></name><name><surname>Forti</surname><given-names>G</given-names></name><name><surname>Maggi</surname><given-names>M</given-names></name><article-title>Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases</article-title><source>Int J Androl</source><year>2009</year><volume>32</volume><fpage>587</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2605.2008.00951.x</pub-id><pub-id pub-id-type="pmid">19226407</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><name><surname>Revnic</surname><given-names>CR</given-names></name><name><surname>Nica</surname><given-names>AS</given-names></name><name><surname>Revnic</surname><given-names>F</given-names></name><article-title>The impact of physical training on endocrine modulation, muscle physiology and sexual functions in elderly men</article-title><source>Arch Gerontol Geriatr</source><year>2007</year><volume>44</volume><issue>Suppl 1</issue><fpage>339</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">17317472</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><name><surname>Vlachopoulos</surname><given-names>C</given-names></name><name><surname>Rokkas</surname><given-names>K</given-names></name><name><surname>Ioakeimidis</surname><given-names>N</given-names></name><name><surname>Stefanadis</surname><given-names>C</given-names></name><article-title>Inflammation, metabolic syndrome, erectile dysfunction and coronary artery disease: common links</article-title><source>Eur Urol</source><year>2007</year><volume>52</volume><fpage>1590</fpage><lpage>1600</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2007.08.004</pub-id><pub-id pub-id-type="pmid">17707576</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><name><surname>Cappelleri</surname><given-names>J</given-names></name><name><surname>Rosen</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>M</given-names></name><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Osterloh</surname><given-names>I</given-names></name><article-title>Diagnostic evaluation of the erectile function domain of the international index of erectile function</article-title><source>Urology</source><year>1999</year><volume>54</volume><fpage>346</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1016/S0090-4295(99)00099-0</pub-id><pub-id pub-id-type="pmid">10443736</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><name><surname>O'Donnell</surname><given-names>AB</given-names></name><name><surname>Araujo</surname><given-names>AB</given-names></name><name><surname>Goldstein</surname><given-names>I</given-names></name><name><surname>McKinlay</surname><given-names>JB</given-names></name><article-title>The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study</article-title><source>J Gen Intern Med</source><year>2005</year><volume>20</volume><fpage>515</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1111/j.1525-1497.2005.0076.x</pub-id><pub-id pub-id-type="pmid">15987326</pub-id></mixed-citation></ref></ref-list></back></article>